Citation:Porter AT, McEwan AJ, Powe JE, Reid R, McGowan DG, Lukka H, et al 1993
Porter AT, McEwan AJ, Powe JE, Reid R, McGowan DG, Lukka H, et al. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys 1993 Apr 2;25(5):805-13 Available from: http://www.ncbi.nlm.nih.gov/pubmed/8478230.
Compare quality appraisals for each clinical question
- Do unsealed radioisotopes improve survival in metastatic prostate cancer?
- What is the effectiveness of unsealed radioisotopes in the management of bone pain from prostate cancer?
- What is the evidence that quality of life is improved with unsealed radioisotopes in prostate cancer?
- What is the toxicity of unsealed radioisotopes for treatment of metastatic prostate cancer?